Altre lingue 2cureX AB

Azioni

2CUREX

SE0010468124

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 12:58:21 25/04/2024			Variaz. 5gg	Var. 1 gen.
0,47 ^SEK	+7,06%		+10,85%	-76,62%

29/02	2curex AB (publ) elegge Grith Hagel come nuovo membro del Consiglio di Amministrazione	CI
22/02	2cureX AB (publ) riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS	16/03
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	29/02
2curex AB Elects Grith Hagel as a New Board Member	29/02
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024	22/02
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	12/02
2cureX AB Announces Change to the Board of Directors	04/01
2cureX AB Announces CEO Changes	29/12
2cureX AB Announces Executive Changes, Effective 1 January 2024	29/12
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop	29/12
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12
2cureX publishes interim report for the third quarter of 2023	23/11
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	14/11
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman	14/11
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	26/10/23
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	25/10/23
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	11/10/23
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation	30/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue 2cureX AB

Azioni

2CUREX

SE0010468124

Altre lingue

Filtri